Cargando…

Regulation of DDAH1 as a Potential Therapeutic Target for Treating Cardiovascular Diseases

Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor that blocks nitric oxide production, while congestive heart failure is associated with increased plasma and tissue ADMA content. Increased plasma ADMA is a strong and independent predictor of all-cause mortality in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaoyu, Fassett, John, Wei, Yidong, Chen, Yingjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710625/ https://www.ncbi.nlm.nih.gov/pubmed/23878601 http://dx.doi.org/10.1155/2013/619207

Ejemplares similares

DDAH1 Deficiency Attenuates Endothelial Cell Cycle Progression and Angiogenesis
por: Zhang, Ping, et al.
Publicado: (2013)

Assessment of DDAH1 and DDAH2 Contributions to Psychiatric Disorders via In Silico Methods
por: Kozlova, Alena A., et al.
Publicado: (2022)

Astaxanthin: A Potential Therapeutic Agent in Cardiovascular Disease
por: Fassett, Robert G., et al.
Publicado: (2011)

Inhibition of DDAH1, but not DDAH2, results in apoptosis of a human trophoblast cell line in response to TRAIL
por: Lumicisi, B.A., et al.
Publicado: (2015)

DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats
por: Zhu, Zhen-Dong, et al.
Publicado: (2019)

Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood
por: Hannemann, Juliane, et al.
Publicado: (2022)

Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in Ddah1 Knockout Mice
por: Hannemann, Juliane, et al.
Publicado: (2020)

Association between variation in the genes DDAH1 and DDAH2 and hypertension among Uygur, Kazakh and Han ethnic groups in China: Associação entre variação de genes DDAH1 e DDAH2 com hipertensão nos grupos étnicos uygur, kazakh e han na China
por: Wang, Zhong, et al.
Publicado: (2016)

Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer
por: Hulin, Julie-Ann, et al.
Publicado: (2020)

Sequence Variation in DDAH1 and DDAH2 Genes Is Strongly and Additively Associated with Serum ADMA Concentrations in Individuals with Type 2 Diabetes
por: Abhary, Sotoodeh, et al.
Publicado: (2010)

Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity
por: Lambden, Simon, et al.
Publicado: (2018)

DDAH1 regulates apoptosis and angiogenesis in human fetal pulmonary microvascular endothelial cells
por: Trittmann, Jennifer K., et al.
Publicado: (2019)

Knock-out of the critical nitric oxide synthase regulator DDAH1 in mice impacts amphetamine sensitivity and dopamine metabolism
por: Kozlova, Alena A., et al.
Publicado: (2023)

DDAH1 Protects against Acetaminophen-Induced Liver Hepatoxicity in Mice
por: Shen, Xiyue, et al.
Publicado: (2022)

DDAH1 Protects against Cardiotoxin-Induced Muscle Injury and Regeneration
por: Feng, Fei, et al.
Publicado: (2023)

A novel DDAH-1 inhibitor improved cardiovascular function in a short-term anesthetized rat model of sepsis
por: Wang, Z, et al.
Publicado: (2011)

Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers
por: Lai, Li, et al.
Publicado: (2016)

Assessment of the direct effects of DDAH I on tumour angiogenesis in vivo
por: Papaevangelou, Efthymia, et al.
Publicado: (2018)

DDAH1/ADMA Regulates Adiponectin Resistance in Cerebral Ischemia via the ROS/FOXO1/APR1 Pathway
por: Zhao, Yichen, et al.
Publicado: (2022)

Proteome Profiling of RNF213 Depleted Cells Reveals Nitric Oxide Regulator DDAH1 Antilisterial Activity
por: Martina, Lia, et al.
Publicado: (2021)

Sequence Variation in the DDAH1 Gene Predisposes for Delayed Cerebral Ischemia in Subarachnoidal Hemorrhage
por: Hannemann, Juliane, et al.
Publicado: (2020)

The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy
por: Wang, Shiyun, et al.
Publicado: (2022)

Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
por: Murphy, Rhys B., et al.
Publicado: (2016)

Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway
por: Zhong, Ying, et al.
Publicado: (2022)

DDAH2 mRNA Expression Is Inversely Associated with Some Cardiovascular Risk-Related Features in Healthy Young Adults
por: Puchau, Blanca, et al.
Publicado: (2009)

N-Acetylcysteine Prevents Hypertension via Regulation of the ADMA-DDAH Pathway in Young Spontaneously Hypertensive Rats
por: Fan, Nai-Chia, et al.
Publicado: (2013)

Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
por: Zhong, Ying, et al.
Publicado: (2023)

The Functional Polymorphism of DDAH2 rs9267551 Is an Independent Determinant of Arterial Stiffness
por: Averta, Carolina, et al.
Publicado: (2022)

Hypermethylation of DDAH2 promoter contributes to the dysfunction of endothelial progenitor cells in coronary artery disease patients
por: Niu, Pan-Pan, et al.
Publicado: (2014)

Microtubule Actin Cross-Linking Factor 1 Regulates Cardiomyocyte Microtubule Distribution and Adaptation to Hemodynamic Overload
por: Fassett, John T., et al.
Publicado: (2013)

Therapeutic Potential of EVs: Targeting Cardiovascular Diseases
por: Laura Francés, Javier, et al.
Publicado: (2023)

Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway
por: Chen, Dong, et al.
Publicado: (2017)

Dietary Supplementation of Caulerpa racemosa Ameliorates Cardiometabolic Syndrome via Regulation of PRMT-1/DDAH/ADMA Pathway and Gut Microbiome in Mice
por: Nurkolis, Fahrul, et al.
Publicado: (2023)

Interference of KLF9 relieved the development of gestational diabetes mellitus by upregulating DDAH2
por: Chen, Weixia, et al.
Publicado: (2021)

Astaxanthin in Cardiovascular Health and Disease
por: Fassett, Robert G., et al.
Publicado: (2012)

Elevated pulmonary arterial pressure and altered expression of Ddah1 and Arg1 in mice lacking cavin-1/PTRF
por: Swärd, Karl, et al.
Publicado: (2013)

DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β‐catenin signaling pathway
por: Ye, Jianxin, et al.
Publicado: (2017)

Chitosan oligosaccharide ameliorates acute lung injury induced by blast injury through the DDAH1/ADMA pathway
por: Liu, Yun-En, et al.
Publicado: (2018)

Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis
por: Wu, Yizheng, et al.
Publicado: (2023)

Scavenger Receptors and Their Potential as Therapeutic Targets in the Treatment of Cardiovascular Disease
por: Stephen, Sam L., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_e9vkqj7gpt8kmldjb1v58g4e68